Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Sun Pharma Launches UNLOXCYT for Advanced Skin Cancer in US

EMA validates submission of Marketing Authorization Application for skin cancer treatment Nidlegy: Sun Pharma, Philogen

Ruchika Sharma5 July 2024 2:30 PM IST

Mumbai: Sun Pharmaceutical Industries Limited and Philogen S.p.A. have announced that the European Medicines Agency (EMA) validated the...

Dr Reddys, Zydus recall products in US over manufacturing issues

Sun Pharma, Dr Reddy's Labs recall products in US over manufacturing issues

Ruchika Sharma5 July 2024 12:18 PM IST

Dr Reddy's Laboratories and Sun Pharma, two prominent pharmaceutical companies, are conducting recalls of products in the United States following...

Language Row Costs Pharmacist: Action Ordered for Giving Wrong Medicine, Refusing Bengali

Alembic Pharma gets tentative USFDA nod for cancer drug Ivosidenib

Ruchika Sharma5 July 2024 11:15 AM IST

Vadodara: Alembic Pharmaceuticals Limited has announced that the Company has received tentative approval from the US Food & Drug...

USFDA Approves Bionpharmas Generic HIV Drug Etravirine

Zydus Lifesciences BP lowering drug receives USFDA tentative nod

Ruchika Sharma4 July 2024 4:46 PM IST

Ahmedabad: Zydus Lifesciences Limited has received tentative approval from the United States Food and Drug Administration (USFDA) to market...

London HC decision fuels continued legal battle between Pfizer, Moderna over COVID vaccine patents

Ruchika Sharma4 July 2024 4:10 PM IST

London: Pfizer and Moderna's legal dispute over their competing COVID-19 vaccines is poised to persist following a mixed ruling from London's...

Rubicon Research Raises Rs 619 Crore Pre-IPO, Eyes October 16 Listing

Nephro Care India IPO subscribed nearly 716 times

Ruchika Sharma4 July 2024 2:30 PM IST

New Delhi: Nephro Care India's initial public offering (IPO) was subscribed 715.85 times on Tuesday, largely driven by robust participation from...

Pfizer files second lawsuit against Metsera, its controlling stockholders, Novo Nordisk

Viatris unit Mylan, former President Rajiv Malik cleared in US Department of Justice generic drug antitrust probe

Ruchika Sharma4 July 2024 1:00 PM IST

Pittsburgh: Viatris Inc. has announced that the Antitrust Division of the U.S. Department of Justice (DOJ) has advised that it no longer...

Sun Pharma pulled up by USFDA for manufacturing issues at Dadra facility

Ruchika Sharma4 July 2024 11:30 AM IST

Mumbai: Sun Pharma did not sufficiently clean and maintain the equipment used in drug manufacturing at its manufacturing plant in Dadra,...

Palamur Biosciences Faces USFDA Warning for Multiple GLP Compliance Failures

Website unlawfully selling versions of Novo Nordisk weight loss drugs gets USFDA warning

Ruchika Sharma3 July 2024 6:45 PM IST

The U.S. Food and Drug Administration (USFDA) said on tuesday it had issued a warning against a website called ozempen.com for illegally selling...

Bad Times for Sanofi Healthcare? Market Signals Suggest Growing Pressure

Dupixent approved in EU as targeted therapy for COPD: Sanofi, Regeneron Pharma

Ruchika Sharma3 July 2024 2:00 PM IST

Paris: Sanofi and Regeneron Pharmaceuticals has announced that the European Medicines Agency (EMA) has approved Dupixent (dupilumab) as...

Eli Lilly in Talks to Acquire Ventyx Biosciences in USD 1 Billion-Plus Deal

Eli Lilly Kisunla gets USFDA okay for early Symptomatic Alzheimer's Disease

Ruchika Sharma3 July 2024 11:20 AM IST

Indianapolis: Eli Lilly has announced that the U.S. Food and Drug Administration (FDA) has approved Alzheimer's treatment Kisunla...

AstraZeneca Pharma India Slapped Rs 11.88 Cr Tax Adjustment for FY23, to Move ITAT

Lynparza, Imfinzi combo recommended for nod in EU by CHMP for endometrial cancer: AstraZeneca

Ruchika Sharma3 July 2024 10:00 AM IST

Cambridge: AstraZeneca has announced that Imfinzi (durvalumab) and Lynparza (olaparib) have been recommended for approval in the European Union (EU)...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok